Suppr超能文献

经皮球囊二尖瓣交界切开术的并发症与死亡率。美国国立心肺血液研究所球囊瓣膜成形术登记处的报告。

Complications and mortality of percutaneous balloon mitral commissurotomy. A report from the National Heart, Lung, and Blood Institute Balloon Valvuloplasty Registry.

出版信息

Circulation. 1992 Jun;85(6):2014-24. doi: 10.1161/01.cir.85.6.2014.

Abstract

BACKGROUND

In response to the increasing use of percutaneous balloon mitral commissurotomy, the National Heart, Lung, and Blood Institute established the Balloon Valvuloplasty Registry in November 1987.

METHODS AND RESULTS

Between November 1, 1987, and October 31, 1989, 738 patients aged 18 or older underwent percutaneous balloon mitral commissurotomy at the clinical sites. Data were prospectively entered into the registry at the time consent was obtained. Serious complications occurred in 87 procedures, or 12%. Death in the laboratory occurred in eight patients, or 1%. Within 30 days there were 24 cumulative deaths, 18 cardiac and six noncardiac. Univariate analysis revealed that older age, a history of cardiac arrest, cerebrovascular disease, dementia, renal insufficiency, cachexia, class IV congestive heart failure, use of an intra-aortic balloon pump, use of sympathomimetic amines, and a high echo score (greater than or equal to 13) were associated with early death (p less than 0.01). Additional univariate predictors included a precommissurotomy mitral valve area of less than 0.7 cm2. Left atrial pressure greater than 12 mm Hg and a mitral valve area of less than 1.5 cm2 after the procedure were also associated with higher 30-day mortality (p less than 0.05). Multivariate analysis identified higher echo score and smaller valve area before the procedure as the strongest predictors of early death (p less than 0.001). Centers that performed more than 25 procedures also had lower complication rates.

CONCLUSIONS

Although percutaneous balloon mitral commissurotomy appears to be effective at relieving the hemodynamic effects of rheumatic mitral stenosis, it does have risks. In properly selected patients, however, it appears to have low morbidity and 30-day mortality. Individual center experience with the procedure also appears to have great impact on complications.

摘要

背景

为应对经皮球囊二尖瓣交界切开术使用的增加,美国国立心肺血液研究所于1987年11月设立了球囊瓣膜成形术登记处。

方法与结果

在1987年11月1日至1989年10月31日期间,738名18岁及以上患者在临床机构接受了经皮球囊二尖瓣交界切开术。在获得同意时前瞻性地将数据录入登记处。87例手术(12%)发生严重并发症。8例患者(1%)在术中死亡。30天内累计死亡24例,其中18例心脏相关死亡,6例非心脏相关死亡。单因素分析显示,高龄、心脏骤停史、脑血管疾病、痴呆、肾功能不全、恶病质、IV级充血性心力衰竭、使用主动脉内球囊反搏、使用拟交感神经胺以及高回声评分(大于或等于13)与早期死亡相关(p<0.01)。其他单因素预测因素包括术前二尖瓣面积小于0.7cm²。术后左心房压大于12mmHg以及二尖瓣面积小于1.5cm²也与30天死亡率较高相关(p<0.05)。多因素分析确定较高的回声评分和术前较小的瓣膜面积是早期死亡的最强预测因素(p<0.001)。进行超过25例手术的中心并发症发生率也较低。

结论

尽管经皮球囊二尖瓣交界切开术似乎能有效缓解风湿性二尖瓣狭窄的血流动力学影响,但确实存在风险。然而,在经过适当选择的患者中,其发病率和30天死亡率似乎较低。各中心的手术经验对并发症似乎也有很大影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验